Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
China: A recent randomized clinical trial has highlighted the potential benefits of intraoperative esketamine in reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results